Literature DB >> 28932276

Contemporary best practice in the evaluation and management of stuttering priapism.

Georgios Kousournas1, Asif Muneer1, David Ralph1, Evangelos Zacharakis1.   

Abstract

Stuttering priapism is rare and under-investigated clinical entity. Although it shares similarities with ischaemic priapism, by definition, stuttering priapism has distinct characteristics that advocate for a different management in the clinical setting. Therefore, the management of stuttering priapism aims primarily to prevent recurrence rather than the resolution of spontaneous attacks. A multimodal approach and the individualization of each case are essential because of the diversity of the condition and the plethora of proposed therapeutic strategies. Understanding the underlying pathophysiology and familiarity with contemporary, past and emerging future agents and therapeutic options are required in order to provide an optimal solution for each patient. In addition, patient counselling and the option to combine therapeutic strategies and challenge second-line therapies are essential weapons in the armament of the urologist. Although further clinical trials and studies are mandatory in order to obtain solid data and provide recommendations, all therapeutic options are analysed, with specific interest in the potential advantages and disadvantages. A structured evaluation procedure is also described.

Entities:  

Keywords:  erectile dysfunction; ischaemic; priapism; recurrent; sickle-cell disease; stuttering

Year:  2017        PMID: 28932276      PMCID: PMC5598804          DOI: 10.1177/1756287217717913

Source DB:  PubMed          Journal:  Ther Adv Urol        ISSN: 1756-2872


  108 in total

1.  Priapism; reasons for failure of therapy.

Authors:  F HINMAN
Journal:  Trans Am Assoc Genitourin Surg       Date:  1959

2.  Neurologic events after partial exchange transfusion for priapism in sickle cell disease.

Authors:  W R Rackoff; K Ohene-Frempong; S Month; J P Scott; B Neahring; A R Cohen
Journal:  J Pediatr       Date:  1992-06       Impact factor: 4.406

3.  The use of high-resolution magnetic resonance imaging in the management of patients presenting with priapism.

Authors:  David J Ralph; Nigel C Borley; Clare Allen; Alex Kirkham; Alex Freeman; Suks Minhas; Asif Muneer
Journal:  BJU Int       Date:  2010-12       Impact factor: 5.588

4.  Daily phosphodiesterase type 5 inhibitor therapy as rescue for recurrent ischemic priapism after failed androgen ablation.

Authors:  Phillip M Pierorazio; Trinity J Bivalacqua; Arthur L Burnett
Journal:  J Androl       Date:  2010-12-02

5.  Penile prosthesis in the management of priapism.

Authors:  A Mireku-Boateng; A G Jackson
Journal:  Urol Int       Date:  1989       Impact factor: 2.089

6.  Priapism, its incidence and seasonal distribution in Finland.

Authors:  R V Kulmala; T A Lehtonen; T L Tammela
Journal:  Scand J Urol Nephrol       Date:  1995-03

7.  Oral ketoconazole for prevention of postoperative penile erection: a placebo controlled, randomized, double-blind trial.

Authors:  Brian J DeCastro; Raymond A Costabile; Leah P McMann; Andrew C Peterson
Journal:  J Urol       Date:  2008-03-18       Impact factor: 7.450

8.  The immediate insertion of a penile prosthesis for acute ischaemic priapism.

Authors:  David J Ralph; Giulio Garaffa; Asif Muneer; Alex Freeman; Rowland Rees; Andrew N Christopher; Sukbinder Minhas
Journal:  Eur Urol       Date:  2008-10-01       Impact factor: 20.096

9.  Follow-up of sickle cell disease patients with priapism treated by hydroxyurea.

Authors:  Sara T O Saad; Camila Lajolo; Simone Gilli; José Francisco C Marques Júnior; Carmen S Lima; Fernando F Costa; Valder R Arruda
Journal:  Am J Hematol       Date:  2004-09       Impact factor: 10.047

10.  hSMR3A as a marker for patients with erectile dysfunction.

Authors:  Yuehong Tong; Moses Tar; Val Monrose; Michael DiSanto; Arnold Melman; Kelvin P Davies
Journal:  J Urol       Date:  2007-05-23       Impact factor: 7.450

View more
  4 in total

1.  Recurrent priapism in spinal cord injury: A case report.

Authors:  Engin Koyuncu; Özlem Taşoğlu; Ali Orhan; Sibel Özbudak Demir; Neşe Özgirgin
Journal:  J Spinal Cord Med       Date:  2019-05-10       Impact factor: 1.985

2.  Dutasteride in the long-term management of stuttering priapism.

Authors:  Ryan C Baker; Rachel L Bergeson; Yooni A Yi; Ellen E Ward; Allen F Morey
Journal:  Transl Androl Urol       Date:  2020-02

3.  Essential thrombocythemia with (type2) calreticulin presented as stuttering priapism case report and review of literature.

Authors:  Elrazi Awadelkarim Ali; Abdulqadir Jeprel Nashwan; Mohamed A Yassin
Journal:  Clin Case Rep       Date:  2020-11-18

Review 4.  Recent advances in understanding and treating priapism.

Authors:  Hussain M Alnajjar; Asif Muneer
Journal:  Fac Rev       Date:  2022-08-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.